Has Foad Elahi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $61,621 in general payments to Foad Elahi, MD across 659 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Foad Elahi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Foad Elahi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Foad Elahi, MD

Pain Medicine · Manteca, CANPI 1154657716

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 84.4% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $27,205 and has fallen 78.4% since, to $5,877 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$61,621in general payments, 2019–2025

Across 659 payments — averaging $93.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$52K
Bioness Inc$5K
Bioventus LLC$2K
Curonix LLC$700
Globus Medical$556
Medtronic$543
plus $1K from 7 others

What the payments were for

Consulting fees$9,98816%
Speaking & faculty fees$31,16051%
Travel & lodging$5,0368%
Food & beverage$10,50917%
Education$4,9298%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	581	$51,999
Bioness Inc	1	$4,929
Bioventus LLC	13	$1,551
Curonix LLC	10	$700
Globus Medical	8	$556
Medtronic(2 entities)	26	$543
Stryker	4	$342
Flowonix Medical Incorporated	1	$248
Zynex Medical, Inc.	1	$235
Painteq LLC	4	$190
Nevro Corp.	6	$176
Abbott	3	$130
Si-bone, Inc.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPECTRA WAVEWRITER$26,569
GENERAL PAIN MANAGEMENT$8,800
Stimrouter for pain$4,929
GENERAL - THERAPIES$4,367
WaveWriter Alpha Prime 16$2,850
Stimrouter Implantable Kit$1,302
WAVEWRITER ALPHA$950
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$317
Prometra II$248
Nexwave$235
MULTIGEN 2$189
SPINEJACK$189
Senza$142
Vyrsa V1$114
Infinion 16$102

How this compares

$61,621 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$266,654

Medicare patients

332

Services billed

15,332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pregabalin	113	$2,602
Gabapentin	129	$1,861
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	62	$715
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	23	$530
Baclofen	40	$338
Tramadol Hcl	37	$164
Venlafaxine Hcl ErVenlafaxine Hcl	26	$155
Nabumetone	15	$86
Methylprednisolone	11	$39
Cyclobenzaprine Hcl	17	$39
Amitriptyline Hcl	13	$39

Paid to pharmacies, not to this prescriber.

Other pain medicine in Manteca

Jason PopeSanta Rosa$2.1M
Ramana NaiduLarkspur$1.4M
Foead GeulaStudio City$1.3M
Krishnan ChakravarthyTemecula$1.3M
Kasra AmirdelfanWalnut Creek$783K
Eric GrigsbyNapa$499K
Jacqueline WeisbeinNapa$494K
Gerald SacksSanta Monica$389K
Samir ShethRoseville$356K
Einar OttestadStanford$352K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →